EZZ Life Science Holdings Limited

ASX:EZZ.AX

1.735 (AUD) • At close June 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

202420232022202120202019
Revenue 66.44337.14315.02222.28717.31511.187
Cost of Revenue 15.4989.947.5149.82813.7536.827
Gross Profit 50.94527.2037.50912.4593.5624.361
Gross Profit Ratio 0.7670.7320.50.5590.2060.39
Reseach & Development Expenses 000000
General & Administrative Expenses 1.2631.1450.8960.6820.2960.9
Selling & Marketing Expenses 37.22920.5582.9697.8431.5541.969
SG&A 38.49222.5883.8658.5262.0823.183
Other Expenses 00.2590.1410.17500
Operating Expenses 41.22922.5885.8669.8862.0823.183
Operating Income 9.7174.6151.7842.7481.481.177
Operating Income Ratio 0.1460.1240.1190.1230.0850.105
Total Other Income Expenses Net 0.2430.241-0.004-0.011-0.0060
Income Before Tax 9.9594.9011.782.7372.151.177
Income Before Tax Ratio 0.150.1320.1180.1230.1240.105
Income Tax Expense 2.9951.2710.4670.7060.5640.354
Net Income 6.9643.631.3122.0311.5860.824
Net Income Ratio 0.1050.0980.0870.0910.0920.074
EPS 0.160.0850.0310.0480.0380.02
EPS Diluted 0.160.0850.0310.0480.0380.02
EBITDA 10.3755.0931.9032.7652.3021.181
EBITDA Ratio 0.1560.1370.1270.1240.1330.106